home.aspx
 
EVENTS

SiriusDecisions 2019 Technology Exchange
SIRIUSDECISIONS 2019 TECHNOLOGY EXCHANGE
December 09-11, 2019
The drive for growth never ceases for b-to-b organizations, and more than ever technology is at the centre of enabling that progress. Gone are the days however when a disparate, disconnected set of platforms strewn across sales, marketing an product can serve the organization effectively. An aligned...

BIOFIT 2019
BIOFIT 2019
December 10-11, 2019
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming fro...

Aspetar

Aspetar is the first specialised Orthopaedic and Sports Medicine Hospital in the Gulf region. It provides the highest possible medical treatment for sports-related injuries in a state-of-the-art facility, staffed by some of the world’s leading sports medicine practitioners and researchers. Through the delivery of excellence in sports medicine, physiotherapy, sports science, orthopaedic surgery and rehabilitation, Aspetar services the needs of football and Sports Clubs and Federations throughout the state of Qatar, and regularly services international athletes and professional sportspeople.

RELATED NEWS


Novartis and Microsoft have inked a five-year deal to use artificial intelligence to design molecules, personalize medication dosing, and optimize the manufacturing of CAR-T cancer therapy, the two companies announced Tuesday. The partnership, whose financial terms were not disclosed, marks the latest and one of the more high-profile signs of the inroads that tech is making into drug development. It promises benefits for both sides: Novartis (NVS) will get Microsoft’s help in mining data i...

READ MORE

The pharma and biotech industry has been hit badly by concerns over high drug prices in the past few years. The initial panic was triggered in September 2015 when the Democratic presidential candidate Hillary Clinton tweeted about "price gouging" and laid out a proposal for combating skyrocketing drug prices....

READ MORE

As government officials continue to scrutinize the high costs of many drugs, particularly the price of life-saving insulin, Indianapolis-based Eli Lilly disclosed data over the weekend that indicates the price for its lead insulin product Humalog dropped by 8 percent over the past five years. In its disclosure, Eli Lilly said that pricing of medications is one of its biggest and most important decisions. Eli Lilly said that across its product portfolio in the United States, the average net price...

READ MORE

Ionis Pharmaceuticals’ RNA-targeted drug Waylivra has been conditionally approved in Europe for the devastating ultra-rare disease Familial Chylomicronemia Syndrome (FCS). The European Commission’s conditional approval means Ionis and its affiliate Akcea will have to re-apply for a marketing authorisation each year for Waylivra (volanesorsen), until they can present confirmatory data to the regulator. As part of the conditional marketing authorisation, Akcea and Ionis will conduct a ...

READ MORE

Let’s say your company has developed a drug for adults with ADHD. However, fewer than 20% of adults with ADHD are currently diagnosed by psychiatrists, in part because ADHD presents differently in adults than it does in children (1). Your company wants to change that through a digital strategy that both helps raise awareness of adult ADHD, and also provides....

READ MORE

In the last decade, new therapies to treat rheumatoid arthritis (RA), a progressive and painful autoimmune disorder, have expanded patients’ treatment options and significantly improved outcomes, helping people with RA achieve disease remission....

READ MORE

EVENTS

eyeforpharma Awards 2019
EYEFORPHARMA AWARDS 2019
December 11-11, 2019
You’ll already know if you’re a winner: your patients are telling you. But now it’s time to be recognised by your peers and the wider healthcare community. The eyeforpharma awards are unique. They’re the only awards that focus exclusively on what matters - value for patients ...

BIOFIT 2019
BIOFIT 2019
December 10-11, 2019
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming fro...